Page last updated: 2024-10-24

verapamil and Low Bone Density

verapamil has been researched along with Low Bone Density in 1 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research Excerpts

ExcerptRelevanceReference
" Adult female and male Sprague-Dawley rats received verapamil in their drinking water at a dosage of 0."1.28Verapamil induces increased bone volume and osteopenia in female rats but has the opposite effect in male rats. ( Samnegård, E; Sjödén, G, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Samnegård, E1
Sjödén, G1

Other Studies

1 other study available for verapamil and Low Bone Density

ArticleYear
Verapamil induces increased bone volume and osteopenia in female rats but has the opposite effect in male rats.
    Calcified tissue international, 1992, Volume: 50, Issue:6

    Topics: Administration, Oral; Animals; Bone and Bones; Bone Diseases, Metabolic; Calcium; Dose-Response Rela

1992